Pharmacological management of bipolar disorder: Japanese expert consensus.

ABSTRACT:

Objectives

The aim of this study was to develop a consensus guideline by certified experts of the Japanese Society of Clinical Neuropsychopharmacology on the psychopharmacological treatment for bipolar disorders I and II (BP-I and BP-II), in order to fill the gap in the literature and provide more concrete guidance for challenging and controversial real-world situations.

Methods

Experts were asked to assess treatment options regarding 19 clinical situations of bipolar disorder with a nine-point Likert scale (one = "disagree" and nine = "agree"). According to the responses from 119 experts, the options were categorized into the first-, second-, and third-line treatments.

Results

For the treatment of BP-I, lithium monotherapy was categorized as a first-line treatment fo

SUBMITTER: Sakurai H 

PROVIDER: S-EPMC7818260 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature